OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,175 | +17.0% | 306 | 0.0% | 0.00% | – |
| Q2 2023 | $1,004 | +17.6% | 306 | -7.6% | 0.00% | – |
| Q1 2023 | $854 | -14.6% | 331 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 331 | -23.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 431 | +6.2% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 406 | -19.8% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 506 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -66.7% | 506 | -4.7% | 0.00% | – |
| Q3 2020 | $3,000 | -50.0% | 531 | -36.1% | 0.00% | – |
| Q2 2020 | $6,000 | – | 831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |